TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
BIOA

BioAge Labs, Inc

Healthcare · Drug Manufacturers - Specialty & Generic · —

8.10$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for BioAge Labs, Inc (BIOA): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 24 · -817.8 % 24 Q4 24 · -52.7 % 24 Q1 25 · 32.1 % 25 Q2 25 · -57.9 % 25 Q3 25 · -9.8 % 25 Q4 25 · -7.7 % 25 Q1 26 · 26.8 % 26 Q2 26 · 10.8 % 26

EPS estimate beaten

Full history 3 of 9 quarters (33%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/05/2026 BioAge Labs, Inc. (BIOA): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?